Literature DB >> 32621001

Endocrine Dysfunction Following Stroke.

Fei Wang1, Ming-Ying Luo2, Lei Zhou3, Li Yang2, Giuseppe Lanzino4, Heng-Jui Chang5, George C Wellman6.   

Abstract

Endocrine dysfunction is known to occur after traumatic brain injury. The purpose of this study was to examine the incidence of various endocrine dysfunctions after a stroke. The Taiwan National Health Insurance Research Database (NHIRD) was searched from 2001 to 2011 for patients with a diagnosis of stroke. Stroke patients were matched by diagnosis date, age, and sex to patients without a stroke. Cox proportional hazards regression analyses were performed to compare the incidence of goiter, acquired hypothyroidism, thyroiditis, pituitary dysfunction, and disorders of the adrenal glands between stroke and non-stroke patients. There were 131,951 patients in the stroke group, and 131,951 in the matched non- stroke group (mean age 66.1 ± 14.9 years). Stroke patients had significantly higher risk of acquired hypothyroidism (crude hazard ratio [cHR] = 1.65, 95% confidence interval [CI]: 1.44, 1.90; adjusted hazard ratio [aHR] = 1.65, 95% CI: 1.42, 1.91), pituitary dysfunction (cHR = 2.32, 95% CI: 1.79, 2.99; aHR = 1.92, 95% CI: 1.46, 2.52), and disorders of the adrenal glands (cHR = 1.79, 95% CI: 1.52, 2.12; aHR =1.62, 95% CI: 1.36, 1.92) than non-stroke patients. Pituitary dysfunction and disorders of the adrenal glands were found in both hemorrhagic stroke and ischemic stroke patients, while hypothyroidism was seen in ischemic stroke patients only. No significant association was found for goiter and thyroiditis. In conclusions, stroke survivors have an approximately 2-fold increased risk of developing acquired hypothyroidism, pituitary dysfunction, or disorders of the adrenal glands. These risks should be taken into account in the management of patients who have ischemic or hemorrhagic strokes. Graphical Abstract.

Entities:  

Keywords:  Endocrine dysfunction; Hemorrhagic stroke; Ischemic stroke; Pituitary

Mesh:

Year:  2020        PMID: 32621001     DOI: 10.1007/s11481-020-09935-6

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  26 in total

1.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

2.  The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment.

Authors:  S H Cheng; T L Chiang
Journal:  JAMA       Date:  1997-07-09       Impact factor: 56.272

3.  Pituitary function and IGF-I levels following ischemic stroke.

Authors:  Sandra Boehncke; Hanns Ackermann; Klaus Badenhoop; Matthias Sitzer
Journal:  Cerebrovasc Dis       Date:  2010-12-04       Impact factor: 2.762

Review 4.  Neuroendocrine hormones as prognostic biomarkers in the setting of acute stroke: overcoming the major hurdles.

Authors:  Alejandro Bustamante; Teresa Garcia-Berrocoso; Victor Llombart; Alba Simats; Dolors Giralt; Joan Montaner
Journal:  Expert Rev Neurother       Date:  2014-11-24       Impact factor: 4.618

5.  Predictors of pituitary dysfunction in patients surviving ischemic stroke.

Authors:  Marta Bondanelli; Maria Rosaria Ambrosio; Anna Carli; Antonella Bergonzoni; Amedeo Bertocchi; Maria Chiara Zatelli; Stefano Ceruti; Domenico Valle; Nino Basaglia; Ettore C degli Uberti
Journal:  J Clin Endocrinol Metab       Date:  2010-07-21       Impact factor: 5.958

6.  Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study.

Authors:  Adomas Bunevicius; Henrikas Kazlauskas; Nijole Raskauskiene; Vinsas Janusonis; Robertas Bunevicius
Journal:  Endocrine       Date:  2013-04-21       Impact factor: 3.633

Review 7.  Endocrine consequences of adult traumatic brain injury.

Authors:  Lucy Ann Behan; Amar Agha
Journal:  Horm Res       Date:  2007-12-10

Review 8.  Prevalence of hypopituitarism in patients with cerebrovascular diseases.

Authors:  M Bondanelli; M R Ambrosio; M C Zatelli; N Basaglia; E C Degli Uberti
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

9.  Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke.

Authors:  Claudine A Blum; Cornelia Mueller; Philipp Schuetz; Felix Fluri; Michael Trummler; Beat Mueller; Mira Katan; Mirjam Christ-Crain
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

Review 10.  Pituitary dysfunction and association with fatigue in stroke and other acute brain injury.

Authors:  H A Booij; W D C Gaykema; K A J Kuijpers; M J M Pouwels; H M den Hertog
Journal:  Endocr Connect       Date:  2018-05-10       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.